Hedge Fund Offers $10M KaloBios Stake, If Shkreli Benched
A North Carolina-based hedge fund has emerged as a stalking horse investor in Chapter 11 turnaround efforts by KaloBios Pharmaceuticals Inc., with a $10 million deal that would sharply limit the...To view the full article, register now.
Already a subscriber? Click here to view full article